Insmed (INSM) Current Deferred Revenue (2010 - 2014)
Insmed (INSM) recorded quarterly Current Deferred Revenue of $423000.0 in Q4 2014, up 31.78% quarter-over-quarter from $321000.0 in Q3 2014, and up 227.91% on a YoY basis from $129000.0 in Q4 2013.
Insmed (INSM) Current Deferred Revenue (2010 - 2014) Analysis & Trends
Insmed's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $423000.0 for Q4 2014.
- In Q4 2014, Current Deferred Revenue rose 227.91% year-over-year to $423000.0; the TTM figure through Dec 2014 stood at $423000.0 (up 227.91% YoY), while the FY2014 annual figure was $423000.0, up 227.91% from the prior year.
- Current Deferred Revenue was $423000.0 for Q4 2014 at Insmed, up from $321000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $423000.0 in Q4 2014 to a low of $121000.0 in Q1 2014.
- Historically, Current Deferred Revenue has averaged $193187.5 across 5 years, with a median of $153000.0 in 2011.
- The sharpest annual moves came in 2011 and 2014: Current Deferred Revenue tumbled 61.19% in 2011, then surged 227.91% in 2014.
- A 5-year view of Current Deferred Revenue shows it stood at $402000.0 in 2010, then sank by 61.19% to $156000.0 in 2011, then decreased by 4.49% to $149000.0 in 2012, then slipped by 13.42% to $129000.0 in 2013, then soared by 227.91% to $423000.0 in 2014.
- The last three Current Deferred Revenue figures came in at $423000.0 (Q4 2014), $321000.0 (Q3 2014), and $167000.0 (Q2 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 423,000.00 |
| Sep 30, 2014 | 321,000.00 |
| Jun 30, 2014 | 167,000.00 |
| Mar 31, 2014 | 121,000.00 |
| Dec 31, 2013 | 129,000.00 |
| Sep 30, 2013 | 134,000.00 |
| Jun 30, 2013 | 139,000.00 |
| Mar 31, 2013 | 144,000.00 |
| Dec 31, 2012 | 149,000.00 |
| Sep 30, 2012 | 151,000.00 |
| Jun 30, 2012 | 152,000.00 |
| Mar 31, 2012 | 154,000.00 |
| Dec 31, 2011 | 156,000.00 |
| Sep 30, 2011 | 154,000.00 |
| Jun 30, 2011 | 195,000.00 |
| Dec 31, 2010 | 402,000.00 |